###begin article-title 0
###xml 81 84 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Identification of a CCR5-Expressing T Cell Subset That Is Resistant to R5-Tropic HIV Infection
###end article-title 0
###begin p 1
###xml 146 147 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 272 273 272 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 298 302 298 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 511 515 511 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 669 673 669 673 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 929 933 929 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 999 1000 999 1000 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1095 1096 1095 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1190 1194 1190 1194 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1261 1262 1261 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 180 185 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 347 350 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 583 588 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 643 648 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 868 871 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1076 1081 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1136 1141 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1243 1248 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1340 1345 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Infection with HIV-1 perturbs homeostasis of human T cell subsets, leading to accelerated immunologic deterioration. While studying changes in CD4+ memory and naive T cells during HIV-1 infection, we found that a subset of CD4+ effector memory T cells that are CCR7-CD45RO-CD45RA+ (referred to as TEMRA cells), was significantly increased in some HIV-infected individuals. This T cell subset displayed a differentiated phenotype and skewed Th1-type cytokine production. Despite expressing high levels of CCR5, TEMRA cells were strikingly resistant to infection with CCR5 (R5)-tropic HIV-1, but remained highly susceptible to CXCR4 (X4)-tropic HIV-1. The resistance of TEMRA cells to R5-tropic viruses was determined to be post-entry of the virus and prior to early viral reverse transcription, suggesting a block at the uncoating stage. Remarkably, in a subset of the HIV-infected individuals, the relatively high proportion of TEMRA cells within effector T cells strongly correlated with higher CD4+ T cell numbers. These data provide compelling evidence for selection of an HIV-1-resistant CD4+ T cell population during the course of HIV-1 infection. Determining the host factors within TEMRA cells that restrict R5-tropic viruses and endow HIV-1-specific CD4+ T cells with this ability may result in novel therapeutic strategies against HIV-1 infection.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 181 182 181 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 452 453 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 480 484 480 484 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 595 599 595 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 699 703 699 703 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 858 859 858 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 955 959 955 959 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 164 169 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 280 285 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 443 448 <span type="species:ncbi:9606">human</span>
###xml 564 569 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 742 747 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 800 803 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 973 978 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1205 1210 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 infection profoundly perturbs the immune system and is characterized by depletion of CD4+ T cells and chronic immune activation, which lead to AIDS. Although HIV-1 targets CD4+ T cells, it also requires a second receptor in order to infect the target cells. The majority of HIV-1 strains that are transmitted use a cell surface molecule called CCR5, which is expressed on a portion of T cells. In this manuscript we identify a subset of human CD4+ T cells, which we termed TEMRA cells, that express CCR5 but still remain resistant to infection. We show that HIV-1 infection is blocked in TEMRA cells after entry of the virus, but before it has a chance to integrate into the cellular genome. TEMRA cells are present at low frequency in HIV-1 uninfected individuals but greatly increase in some HIV-infected individuals, which correlates with higher CD4+ T cell numbers. These findings provide the basis for future studies to understand the role of TEMRA cells during HIV-1 infection and identify the host factors that could restrict the virus. This knowledge may be used to endow susceptible T cells with the ability to resist infection and result in novel vaccine or therapeutic strategies against HIV-1 infection.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b001">1</xref>
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b004">4</xref>
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b002">2</xref>
###xml 122 127 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 264 269 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 428 433 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Chronic immune activation and homeostatic disturbance of T cell subsets that accompany viral replication are hallmarks of HIV-1 infection [1-4]. The cause and implications of these profound quantitative and qualitative changes in CD4+ memory T cell subsets during HIV-1 infection are still not well understood [2]. Elucidating the causal relationships between perturbed naive and memory T cell compartments during the course of HIV-1 infection could be critical in understanding its pathogenesis.
###end p 6
###begin p 7
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 57 58 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</sub>
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b005">5</xref>
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b008">8</xref>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b009">9</xref>
###xml 330 331 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 379 381 379 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 405 407 405 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 416 417 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b008">8</xref>
###xml 421 423 421 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 621 622 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b008">8</xref>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b010">10</xref>
###xml 642 644 642 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 742 744 742 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 855 857 855 857 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 976 977 976 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b011">11</xref>
###xml 990 992 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b016">16</xref>
###xml 1115 1117 1115 1117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 1196 1198 1196 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b017">17</xref>
###xml 1199 1201 1199 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b018">18</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 918 923 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1043 1048 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1318 1325 <span type="species:ncbi:9606">persons</span>
Human T cells are categorized as naive (TN) and memory (TM) subsets based on expression of CD45RA and CD45RO isoforms, respectively [5-8]. It is now known that memory T cells are comprised of distinct subsets that can be identified based on other surface markers and effector functions [9]. Sallusto and colleagues defined two CD4+ memory T cell subsets, termed central memory (TCM) and effector memory (TEM) cells [8]. TEM cells have low expression levels of the chemokine receptor CCR7 and lymph node homing receptor CD62L, express receptors for migration to inflamed tissues, and display immediate effector functions [8,10]. In contrast, TCM cells express high levels of CCR7 and lack potent effector functions. It has been proposed that TCM cells are responsible for maintaining long-term memory, and upon re-exposure to antigens, differentiate into TEM cells with effector functions. Prior studies indicated that HIV-1 preferentially infects memory, rather than naive CD4+ T cells [11-16], possibly because of exclusive expression of the HIV-1 coreceptor CCR5 on memory T cells. Within the memory population, TEM cells are enriched for expression of CCR5 relative to other CD4 memory cells [17,18], suggesting that they may be primary targets for CCR5-tropic (R5-tropic) viruses that predominate in most infected persons.
###end p 7
###begin p 8
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b019">19</xref>
###xml 207 208 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 210 212 210 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 239 240 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 242 246 242 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 361 362 361 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 364 368 364 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 513 514 513 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 155 160 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 285 288 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 426 431 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 544 547 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Because chronic HIV-1 infection disrupts the balance between naive and memory T cell subsets [19], we characterized the distribution of these cells during HIV-1 infection. We found that a small subset of CD4+ TEM cells, which we called CD4+ TEMRA cells, were greatly increased in some HIV-infected individuals relative to uninfected individuals. Remarkably, CD4+ TEMRA cells displayed a specific post-entry block to R5-tropic HIV-1, despite expressing high levels of CCR5. Accumulation of this effector memory CD4+ T cell subset during chronic HIV infection could have important implications in understanding intrinsic resistance to the virus and perturbation of T cell compartments in infected individuals.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human T Cell Subset Distribution during HIV-1 Infection
###end title 10
###begin p 11
###xml 295 296 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 372 373 372 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 381 382 381 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 386 387 386 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 415 417 415 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 425 426 425 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 464 466 464 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 472 473 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 476 484 476 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g001">Figure 1</xref>
###xml 563 569 563 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/dull</sup>
###xml 573 574 573 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 595 603 595 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g001">Figure 1</xref>
###xml 721 729 721 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g001">Figure 1</xref>
###xml 800 801 800 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 827 828 827 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 830 834 830 834 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b020">20</xref>
###xml 948 949 948 949 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 951 955 951 955 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 979 983 979 983 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1035 1036 1035 1036 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1042 1043 1042 1043 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1047 1048 1047 1048 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1068 1069 1068 1069 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1088 1092 1088 1092 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 1126 1130 1126 1130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1223 1231 1223 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g001">Figure 1</xref>
###xml 1254 1258 1254 1258 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 1264 1268 1264 1268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1334 1342 1334 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g001">Figure 1</xref>
###xml 1384 1385 1384 1385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 1474 1476 1474 1476 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 1516 1524 1516 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g001">Figure 1</xref>
###xml 47 50 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 64 67 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 512 515 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 695 698 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1141 1146 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1175 1178 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1195 1198 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1308 1311 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1423 1426 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The dynamics of T cell changes were studied in HIV-infected and HIV-uninfected individuals by staining their peripheral blood mononuclear cells (PBMCs) with monoclonal antibodies against CD3, CD4, CCR7, and CD45RO cell surface molecules. In most uninfected individuals, this analysis divides CD4+ T cells into three subsets that can be readily quantified: naive T cells (TN; CD45RO-CCR7+), central memory T cells (TCM; CD45RO+CCR7+), and effector memory T cells (TEM; CCR7-) (Figure 1A, left panel). However, in HIV-uninfected individuals, a fourth subset (CD45RO-/dullCCR7-) was also observed (Figure 1A), albeit with a low frequency (0.5%-3%). This subset was greatly increased in some of the HIV-infected individuals (Figure 1A, right panel). Because these cells resembled a previously defined CD8+ T cell subset (called CD8+ TEMRA cells) with effector functions that expressed CD45RA with effector functions [20], we tentatively termed them CD4+ TEMRA cells (referred to as TEMRA cells hereafter). Conversely, we denoted the CD45RO+CD45RA-CCR7- effector memory CD4+ T cell subset as TEMRO cells. The relationship between TEMRA cells and HIV-1 infection was studied in 33 HIV-infected and 30 HIV-uninfected individuals (Figure 1B). The proportion of TEMRO and TEMRA subsets was significantly increased in HIV-infected individuals (Figure 1B). On the other hand, the proportion of TN cells was significantly decreased in HIV-infected individuals, while the proportion of TCM cells remained similar in both groups (Figure 1B).
###end p 11
###begin title 12
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 37 41 37 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
Phenotypic Characterization of CD4+ TEMRA Cells
###end title 12
###begin p 13
###xml 24 28 24 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 133 137 133 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 179 180 179 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 238 239 238 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b020">20</xref>
###xml 316 317 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 328 329 328 329 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 332 334 332 334 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 337 341 337 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 348 352 348 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 549 550 549 550 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 636 637 636 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 639 641 639 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 644 648 644 648 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 655 659 655 659 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 667 675 667 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g002">Figure 2</xref>
###xml 748 752 748 752 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 758 762 758 762 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 784 785 784 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 787 788 787 788 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 794 796 794 796 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 804 812 804 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g002">Figure 2</xref>
###xml 831 833 831 833 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 839 843 839 843 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 852 856 852 856 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 913 914 913 914 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 922 930 922 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g002">Figure 2</xref>
###xml 973 977 973 977 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1003 1004 1003 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1051 1052 1051 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1058 1064 1058 1064 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/dull</sup>
###xml 44 47 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 368 371 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 385 388 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The high proportion of TEMRA cells found in HIV-infected individuals prompted further analysis of this subset. We hypothesized that TEMRA cells are a subset of effector memory CD4+ T cells, analogous to a subset recently described for CD8+ T cells with the same surface marker phenotype [20]. The four subsets of CD4+ T cells (TN, TCM, TEMRO, and TEMRA) obtained from HIV-infected and HIV-uninfected individuals were analyzed for expression of cell surface molecules known to be expressed differentially in naive, memory, and effector T cells. All TN cells expressed CD28, CD27, CD7, and CD62L, with progressively less expression on CD4+ TCM, TEMRO, and TEMRA cells (Figure 2). In contrast, expression of CD11b, CD57, and HLA-DR were increased on TEMRO and TEMRA cells compared to CD4+ TN and TCM cells (Figure 2). In contrast to TCM and TEMRO cells, TEMRA cells also expressed high levels of CD45RA, similar to TN cells (Figure 2, top panel). This profile suggested that TEMRA cells are a subset of CD4+ effector memory T cells with a peculiar CD45RA+CD45RO-/dull phenotype.
###end p 13
###begin title 14
Proliferative Capacity and Apoptosis of Effector Memory T Cell Subsets
###end title 14
###begin p 15
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b008">8</xref>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b020">20</xref>
###xml 151 152 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 280 288 280 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g001">Figure 1</xref>
###xml 438 446 438 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g003">Figure 3</xref>
###xml 505 506 505 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 512 514 512 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 522 530 522 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g003">Figure 3</xref>
###xml 543 547 543 547 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 559 563 559 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 591 599 591 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g003">Figure 3</xref>
###xml 202 205 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Differentiated effector memory T cells have a reduced proliferative capacity [8,20]. To assess the relative proliferative capacity of the different CD4+ T cell subsets, each subset was purified from an HIV-uninfected individual according to CCR7 and CD45RO expression as shown in Figure 1A, and stimulated with dendritic cells (DCs) pulsed with superantigen (staphylococcal enterotoxin B [SEB]). Activated T cells were counted at day 12 (Figure 3A). DC-mediated activation caused robust cell division of TN and TCM cells (Figure 3A), whereas TEMRO cells and TEMRA cells divided fewer times (Figure 3A).
###end p 15
###begin p 16
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b009">9</xref>
###xml 182 186 182 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 505 506 505 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 512 514 512 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 522 530 522 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g003">Figure 3</xref>
###xml 579 583 579 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 589 593 589 593 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 634 642 634 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g003">Figure 3</xref>
The reduced proliferative capacity of effector T cells correlates with a decrease in telomere length and with an increased propensity to undergo apoptosis [9]. To determine whether TEMRA cells undergo apoptosis similar to effector T cells, all T cell subsets were stained with a marker of apoptosis (Annexin V) before and after cells were stimulated through the T cell receptor (TCR) by anti-CD3 plus anti-CD28 antibodies for 18 h. A higher proportion of effector T cells underwent apoptosis compared to TN and TCM cells (Figure 3B). Levels of apoptosis were comparable between TEMRO and TEMRA cells before and after TCR stimulation (Figure 3B).
###end p 16
###begin title 17
###xml 20 25 <span type="species:ncbi:9606">Human</span>
Cytokine Profile of Human Effector Memory T Cells
###end title 17
###begin p 18
###xml 15 17 15 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 121 122 121 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 128 130 128 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b008">8</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b010">10</xref>
###xml 189 193 189 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 199 203 199 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b008">8</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b010">10</xref>
###xml 234 238 234 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 355 356 347 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 362 364 354 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 372 380 364 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g003">Figure 3</xref>
###xml 385 389 377 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 490 494 478 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 502 510 490 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g003">Figure 3</xref>
###xml 556 560 544 548 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 712 714 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b021">21</xref>
###xml 744 748 732 736 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 862 866 850 854 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 902 906 890 894 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 911 913 899 901 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 923 932 911 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0030058-sg001">Figure S1</xref>
###xml 969 973 957 961 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
A hallmark of TEM cells is secretion of greater quantities of cytokines when stimulated through the TCR, as compared to TN and TCM cells [8,10]. We therefore explored cytokine profiles of TEMRO and TEMRA subsets. As expected, [8,10] TEMRO cells secreted greater amounts of most cytokines assayed (IL-4, IL-5, IL-10, TNF-alpha, and IFN-gamma) compared to TN and TCM cells (Figure 3C). TEMRA cells secreted high levels of IFN-gamma, but much lower levels of IL-4, IL-5, or IL-10 compared to TEMRO cells (Figure 3C). This cytokine profile suggested that the TEMRA subset is skewed towards a Th1 phenotype. Recently, a cell surface molecule called CRTH2 was shown to be highly expressed on Th2 but not on Th1 cells [21]. To confirm Th1 skewing of TEMRA cells, we analyzed the surface expression of CRTH2. In agreement with the cytokine profile, significantly fewer TEMRA cells expressed CRTH2 compared to TEMRO or TCM subsets (Figure S1). Taken together, we conclude that TEMRA cells are differentiated effector memory T cells that are skewed toward a Th1 phenotype.
###end p 18
###begin title 19
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Infection of TCR-Stimulated CD4+ T Cell Subsets
###end title 19
###begin p 20
###xml 9 13 9 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 184 185 184 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 188 190 188 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 193 197 193 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 204 208 204 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b022">22</xref>
###xml 59 62 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 143 148 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 238 241 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 255 258 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 439 442 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 447 450 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 493 496 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 501 504 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 613 639 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 662 665 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Because TEMRA cells were proportionately increased in some HIV-infected individuals, we next investigated the susceptibility of these cells to HIV-1 infection. For these experiments, TN, TCM, TEMRO, and TEMRA cells purified from PBMCs of HIV-infected and HIV-uninfected individuals were activated through the TCR to render them susceptible to infection. The activated T cells were then infected with either R5-tropic replication-competent HIV (R5.HIV), CXCR4 (X4)-tropic replication-competent HIV (X4.HIV), or replication-defective viruses that only undergo a single round of replication and are pseudotyped with vesicular stomatitis virus glycoprotein G (VSV-G.HIV). Each virus used here encoded green fluorescent protein (GFP) that was used to quantify infection by flow cytometry at specific time points after inoculation [22].
###end p 20
###begin p 21
###xml 100 101 100 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 104 106 104 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 109 113 109 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 120 124 120 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 175 183 175 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g004">Figure 4</xref>
###xml 188 192 188 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 198 202 198 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 302 310 302 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g004">Figure 4</xref>
###xml 461 470 461 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0030058-sg002">Figure S2</xref>
###xml 573 575 573 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 581 585 581 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 633 634 633 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 642 650 642 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g004">Figure 4</xref>
###xml 738 746 738 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g004">Figure 4</xref>
###xml 764 768 764 768 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 836 844 836 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g004">Figure 4</xref>
###xml 934 938 934 938 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 946 954 946 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g004">Figure 4</xref>
###xml 1045 1046 1045 1046 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 1049 1051 1049 1051 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 1058 1062 1058 1062 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 1135 1139 1135 1139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1198 1206 1198 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g004">Figure 4</xref>
###xml 1238 1242 1238 1242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1335 1343 1335 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g004">Figure 4</xref>
###xml 1375 1379 1375 1379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1477 1485 1477 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g004">Figure 4</xref>
###xml 62 67 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 148 151 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 378 381 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 514 517 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 563 566 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 831 834 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 987 990 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1297 1300 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1436 1439 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Prior to the infectivity assay, we analyzed the expression of HIV-1 co-receptors CCR5 and CXCR4 on TN, TCM, TEMRO, and TEMRA cells isolated from an HIV-uninfected individual (Figure 4A). TEMRA and TEMRO cells expressed the highest levels of CCR5, while all four subsets expressed high levels of CXCR4 (Figure 4A). In addition, the median CCR5 expression was quantitated from 20 HIV-infected individuals, and the similar subset expression trends were confirmed (Figure S2). When each T cell subset isolated from an HIV-uninfected individual was challenged with R5.HIV, CD4 TCM and TEMRO cells were more susceptible to infection than TN cells (Figure 4B), most likely reflecting high CCR5 surface expression levels on these memory T cells (Figure 4A). In contrast, TEMRA cells were resistant to a high multiplicity challenge with R5.HIV (Figure 4B, top panel). This was an unexpected finding given the high cell surface CCR5 levels on TEMRA cells (Figure 4A). At day 12 post-infection, R5.HIV spread through the cultures, producing more infected TN, TCM, and TEMRO cells as compared to 5 d post-infection. Even at this late time point, TEMRA cells remained almost completely refractory to infection (Figure 4B, second panel). In contrast, TEMRA cells were similarly susceptible to infection with X4.HIV, as well as other T cell subsets (Figure 4B, third panel). Surprisingly, TEMRA cells were also 5- to 10-fold less susceptible to VSV-G.HIV infection than other T cell subsets (Figure 4B, bottom panel).
###end p 21
###begin p 22
###xml 51 55 51 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 472 480 472 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g005">Figure 5</xref>
###xml 609 610 609 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 613 615 613 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 622 626 622 626 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 677 681 677 681 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 689 697 689 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g005">Figure 5</xref>
###xml 817 825 817 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g005">Figure 5</xref>
###xml 831 832 831 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g005">5</xref>
###xml 1024 1028 1024 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef,</italic>
###xml 1040 1048 1040 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g005">Figure 5</xref>
###xml 1072 1076 1072 1076 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 270 273 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 280 283 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 534 537 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 578 581 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 717 720 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 911 916 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 990 995 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We then sought to determine whether over time the TEMRA subset would progressively become more susceptible to infection post-activation, or whether these cells were being killed in culture by rapidly replicating virus. For this experiment, T cells were infected with R5.HIV or X4.HIV for 2 d at different multiplicities of infection (MOIs) and then washed to remove input virus. Infection was quantified based on GFP expression at different time points after inoculation (Figure 5A), and viral replication was assessed by quantifying HIV p24 protein in culture supernatants. R5.HIV replicated efficiently in TN, TCM, and TEMRO cells, but there was little or no replication in TEMRA cells (Figure 5B). In contrast, X4.HIV infected and replicated efficiently in all four subsets and rapidly killed most of the T cells (Figure 5A and 5B, right panels; unpublished data). Similar results were observed when primary HIV-1 isolates, utilizing different R5-tropic, X4-tropic, and R5X4-dual tropic HIV-1 envelopes that also express nef, were used (Figure 5C). The infectivity of TEMRA cells activated with SEB-pulsed DCs also remained identical (unpublished data).
###end p 22
###begin p 23
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b023">23</xref>
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b024">24</xref>
###xml 152 156 152 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 184 185 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 193 201 193 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g002">Figure 2</xref>
###xml 225 226 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 324 328 324 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 334 338 334 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 378 379 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 388 389 388 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 439 440 439 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 449 450 449 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 463 467 463 467 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 539 540 539 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 549 550 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 563 567 563 567 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 625 633 625 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g006">Figure 6</xref>
###xml 664 665 664 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 674 675 674 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 693 697 693 697 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 703 707 703 707 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 763 771 763 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g006">Figure 6</xref>
###xml 822 826 822 826 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 898 899 898 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 112 115 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 846 849 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The surface marker CD57 identifies terminally differentiated cells [23], and expansion of CD57+ cells occurs in HIV-infected individuals [24]. Because TEMRA cells were enriched in CD57+ cells (Figure 2), we asked whether CD57+ T cells were differentially susceptible to R5-tropic or X4-tropic viruses. For this experiment, TEMRA and TEMRO cells were further subdivided into CD57+ and CD57- subsets by flow cytometry cell sorting. Both CD57+ and CD57- subsets of TEMRA cells were resistant to infection by R5-tropic virus, whereas both CD57+ and CD57- subsets of TEMRO cells remained susceptible to R5-tropic virus infection (Figure 6, top panel). However, the CD57+ and CD57- subsets of both TEMRO and TEMRA cells were similarly susceptible to X4-tropic viruses (Figure 6, bottom panel). Thus, the relative resistance of TEMRA cells to R5-tropic HIV was not attributable to enrichment with the CD57+ subset.
###end p 23
###begin p 24
###xml 75 79 75 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 180 181 180 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 184 186 184 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 189 193 189 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 200 204 200 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 418 422 418 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 534 542 534 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g007">Figure 7</xref>
###xml 673 677 673 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 770 778 770 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g007">Figure 7</xref>
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 234 237 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 654 657 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We next investigated where in the HIV-1 life cycle R5-tropic infection of TEMRA cells was blocked. Because large numbers of cells were required for these experiments, we expanded TN, TCM, TEMRO, and TEMRA cells purified from PBMCs of HIV-uninfected individuals using SEB-pulsed DCs for 12 d in IL-2-containing medium. In order to verify that CCR5 expression levels were maintained on expanded T cell subsets and that TEMRA cells remained resistant to R5-tropic infection, CCR5 expression was determined post-activation and expansion (Figure 7A, top panel). The expanded subsets were then reactivated with SEB-pulsed DCs and subsequently infected with R5.HIV. Although the TEMRA cells maintained very high CCR5 expression, they remained resistant to R5-tropic infection (Figure 7A, bottom panel).
###end p 24
###begin p 25
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b025">25</xref>
###xml 200 202 200 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 205 209 205 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 216 220 216 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 319 323 319 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 393 394 393 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 501 509 501 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g007">Figure 7</xref>
###xml 583 587 583 587 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 165 168 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 256 259 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 264 267 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 278 281 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 559 562 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We first asked whether the block of R5-tropic infection was at the level of fusion. For this experiment, we employed a recently developed reporter assay to quantify HIV particle entry [25]. Expanded TCM, TEMRO, and TEMRA cells were infected with either R5.HIV, X4.HIV, or VSV-G.HIV. Fusion of these three viruses with TEMRA cells was similarly efficient, whereas fusion was inhibited in both TN and Jurkat cells, which do not express CCR5, or when cells were pre-treated with T20, a fusion inhibitor (Figure 7B). Collectively, these data indicate that the R5.HIV infection block in TEMRA cells is post-fusion.
###end p 25
###begin p 26
###xml 143 147 143 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 313 317 313 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 442 450 442 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g007">Figure 7</xref>
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 210 213 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 218 221 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 230 233 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 341 344 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 355 358 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 437 440 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We next conducted analysis of the stage in the HIV-1 life cycle at which R5-tropic and VSV-G pseudotyped virus replication was blocked in the TEMRA subset. Late reverse transcripts in cells infected with VSV-G.HIV, R5.HIV, and X4.HIV were analyzed. Infection was blocked at the level of reverse transcription in TEMRA cells infected with R5.HIV and VSV-G.HIV, suggesting an early block to infection in these cells that did not affect X4.HIV (Figure 7C).
###end p 26
###begin p 27
###xml 278 282 278 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 466 470 466 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 512 520 512 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g007">Figure 7</xref>
###xml 494 497 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 507 510 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 565 570 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Because we did not see the accumulation of late reverse transcription products, we wanted to understand whether earlier steps in reverse transcription were impaired. Therefore, we investigated the initiation of reverse transcription of R5-tropic and VSV-G pseudotyped virus in TEMRA cells. Early reverse transcription was assessed by the presence of strong-stop, minus-strand viral DNA (R/U5 DNA) by quantitative real-time PCR. Early transcripts were not formed in TEMRA cells infected with R5.HIV or VSV-G.HIV (Figure 7D). These data suggest that the block in the HIV-1 life cycle occurs at or prior to the initiation of reverse transcription.
###end p 27
###begin title 28
###xml 16 20 16 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 59 62 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Correlation of TEMRA Cell Levels with CD4+ Cell Numbers in HIV-Infected Individuals
###end title 28
###begin p 29
###xml 19 23 19 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 183 187 183 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 248 249 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 305 306 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 323 331 323 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g001">Figure 1</xref>
###xml 358 360 358 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 368 372 368 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 376 380 376 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 423 424 423 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 441 449 441 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g001">Figure 1</xref>
###xml 517 521 517 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 527 531 527 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 641 643 641 643 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 651 659 651 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g008">Figure 8</xref>
###xml 696 698 696 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 722 723 722 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 794 795 794 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 810 818 810 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g008">Figure 8</xref>
###xml 880 882 880 882 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 910 911 910 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 977 981 977 981 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 989 997 989 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g008">Figure 8</xref>
###xml 1100 1102 1100 1102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 1110 1118 1110 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g008">Figure 8</xref>
###xml 1184 1188 1184 1188 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1219 1220 1219 1220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1248 1249 1248 1249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 1273 1281 1273 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g008">Figure 8</xref>
###xml 1334 1338 1334 1338 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1435 1436 1435 1436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 59 62 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 217 220 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1469 1474 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our findings that TEMRA cells are expanded in a portion of HIV-infected individuals and are highly resistant to R5-tropic infection prompted us to examine relationships between high TEMRA cells and CD4 numbers. Among HIV-infected individuals, the TN cell percentage correlated positively with absolute CD4+ T cell numbers (Figure 1B). Conversely, the total TEM cell (TEMRO + TEMRA) percentage correlated negatively with CD4+ T cell numbers (Figure 1B; unpublished data). To further delineate the association between TEMRO and TEMRA cell proportions and CD4 numbers, we subdivided infected individuals into three groups based on their total TEM cells (Figure 8). Infected individuals in whom the TEM percentage of their CD4+ T cells was similar to healthy individuals (bottom group) had high CD4+ cell numbers (Figure 8; unpublished data). In contrast, the group with a very high TEM cell percentage had low CD4+ T cell numbers, and all of these individuals had high levels of TEMRO cells (Figure 8, top group). Importantly, however, when we subdivided the infected individuals with median levels of TEM cells (Figure 8, middle group), a highly significant association between higher TEMRA cell percentage and higher CD4+ T cell numbers and higher TN cells was established (Figure 8). These results imply that a greater proportion of TEMRA cells within the effector T cell subset may identify individuals with better preservation of CD4+ cell numbers, and possibly slow HIV-1 disease progression.
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 132 133 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 135 139 135 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 554 555 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 559 560 559 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 662 664 662 664 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b023">23</xref>
###xml 695 696 695 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 705 706 705 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 719 723 719 723 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 776 784 776 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g005">Figure 5</xref>
###xml 801 802 801 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 835 839 835 839 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 847 855 847 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g002">Figure 2</xref>
###xml 865 869 865 869 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 222 227 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 277 282 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 412 417 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 501 504 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 759 764 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 964 969 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our investigation of memory T cell subsets during HIV-1 infection led to the discovery of a unique subset of CD4+ T cells called CD4+ TEMRA cells. We found that these cells are highly susceptible to infection by X4-tropic HIV-1 but are almost completely resistant to R5-tropic HIV-1 despite high levels of cell surface CCR5 expression. These cells are also relatively resistant to infection by VSV-G pseudotyped HIV-1. Our findings are consistent with a recent ex vivo analysis of T cell subsets from HIV-infected individuals, which demonstrated that CD4+CD57+ effector memory T cells were associated with approximately ten times fewer copies of viral DNA than TCM cells [23]. Although both CD57+ and CD57- subsets of TEMRA cells displayed the same R5-tropic HIV-1 infection (Figure 5C), overall, CD57+ cells are more enriched within TEMRA cells (Figure 2). Thus, TEMRA cells represent the first unique subpopulation of CD4+ T cells that are uniquely resistant to HIV-1 infection and may emerge as a consequence selection during infection.
###end p 31
###begin p 32
###xml 47 51 47 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 346 350 346 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 445 449 445 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 531 535 531 535 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 750 754 750 754 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 782 783 782 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 787 788 787 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 838 842 838 842 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1051 1055 1051 1055 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 386 391 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 729 734 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 821 826 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 978 981 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1041 1046 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Further studies are required to elucidate how TEMRA cells can be resistant to R5-tropic infection despite high levels of CCR5 expression, yet remain susceptible to X4-tropic viruses. In order to exclude that this restriction was at the level of post-entry and not because of downregulation or block of CCR5 by beta-chemokines, we showed that 1) TEMRA cells permitted entry of R5-tropic HIV-1 as measured by the BlaM-Vpr virion fusion assay, 2) TEMRA cells continued to express high levels of CCR5 at the time of infection, 3) and TEMRA cells were partly less susceptible to VSV-G pseudotyped viruses that bypass the coreceptor requirement. Taken together, these results indicate that the post-entry pathway followed by R5-tropic HIV-1 may differ in TEMRA cells compared to other CD4+CCR5+ T cell subsets and to X4-tropic HIV-1-infecting TEMRA cells. It is conceivable that either signaling or the entry pathway through the CXCR4 receptor elicits intracellular events needed for HIV replication or bypasses mechanisms that otherwise restrict HIV-1 in TEMRA cells.
###end p 32
###begin p 33
###xml 89 90 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 370 374 370 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 625 629 625 629 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 710 714 710 714 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 801 805 801 805 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1016 1017 1016 1017 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1041 1042 1041 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1046 1047 1046 1047 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1052 1053 1052 1053 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1055 1059 1055 1059 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1127 1128 1127 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1130 1134 1130 1134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1161 1162 1161 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b008">8</xref>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b020">20</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b026">26</xref>
###xml 1202 1203 1202 1203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1205 1209 1205 1209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1247 1248 1247 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1250 1254 1250 1254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1381 1382 1381 1382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1384 1388 1384 1388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 127 132 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 192 197 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 265 270 <span type="species:ncbi:9606">human</span>
###xml 321 326 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 384 389 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 770 775 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Elucidating cellular mechanisms that determine why some, but not all, CCR5-expressing CD4+ T cells are permissive to R5-tropic HIV-1 infection could provide clues to identify natural cellular HIV-1 barriers. Our findings suggest that at least one subset of primary human T cells display intrinsic restriction that limits HIV-1 infection. The presence of differentiated TEMRA cells in HIV-1 infected individuals and in uninfected individuals, albeit at lower frequency, suggests that these cells expand and survive during the course of the normal immune response. These findings also pose several important questions: How do TEMRA cells arise? Are they repeatedly stimulated memory T cells? What aspect of the TEMRA cell differentiation program renders them resistant to HIV-1 infection? For example, TEMRA cells displayed a preferential Th1 phenotype and exhibited a reduced proliferative capacity as well as a cell surface marker and cytokine profile characteristic of highly differentiated T cells. A subset of CD8+ T cells that are CD45RA+CD27- (CD8+ TEMRA cells) has been shown to display similar phenotypic features to CD4+ TEMRA cells characterized here [8,20,26]. It is not yet clear whether CD4+ TEMRA cells are functionally similar to CD8+ TEMRA cells or what role these subsets play during chronic viral infections. The homeostatic mechanisms that induce and maintain CD4+ TEMRA cells also remains to be determined.
###end p 33
###begin p 34
###xml 18 22 18 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 473 477 473 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 530 532 530 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 564 568 564 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 620 621 620 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 634 635 634 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 654 658 654 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b017">17</xref>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b018">18</xref>
###xml 962 964 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b027">27</xref>
###xml 965 967 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b030">30</xref>
###xml 1038 1042 1038 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 1078 1082 1078 1082 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1118 1122 1118 1122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1251 1255 1251 1255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 1428 1429 1428 1429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1535 1537 1535 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b031">31</xref>
###xml 1597 1598 1597 1598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 87 90 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 177 180 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 338 343 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 498 501 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 689 692 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 693 701 <span type="species:ncbi:9606">patients</span>
###xml 908 913 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1053 1056 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1164 1169 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1197 1200 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1291 1294 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1399 1404 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1460 1465 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1554 1557 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1579 1584 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1697 1702 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our finding that TEMRA cells correlate with higher CD4+ T cell numbers in a portion of HIV-infected individuals suggests that virus infection may positively drive selection for HIV-resistant cells in vivo, a phenomenon previously observed only in cell culture but usually involving loss of CD4 expression. Studies using animal models for HIV-1 infection may aid in determining whether there is a causal relationship between virus infection and selective enrichment of the TEMRA subset. Remarkably, HIV-infected individuals whose TEM cells were composed mostly of TEMRA cells were significantly associated with higher CD4+ T cell and TN cell levels. How TEMRA cells accumulate or expand in HIV patients, and whether they have a protective role against progression of disease, remains to be determined. Memory and effector T cells are enriched for CCR5 expression [17,18], suggesting that they are targets for HIV-1, especially T cells resident in the gut tissue [27-30]. It is conceivable that after continuous destruction of susceptible TEMRO cells, an HIV-resistant subset of TEMRA cells is selected. Alternatively, TEMRA cells may have a protective role against HIV-1 infection, perhaps because HIV-specific T cells are enriched in this subset. If TEMRA cells contain a high proportion of HIV-specific effector T cells, this would overcome a potential Achilles' heel of the immune response during HIV-1 infection; that is, CD4+ T cells that are activated by HIV-1 antigens themselves become highly susceptible targets for the virus [31]. Conferring an HIV-resistant ability to HIV-1-specific CD4+ T cells could lead to novel strategies aimed at potentiating a protective immune response against HIV-1 infection.
###end p 34
###begin p 35
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b032">32</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b034">34</xref>
###xml 239 240 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b035">35</xref>
###xml 490 494 490 494 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 655 659 655 659 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 185 188 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 317 320 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 330 333 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 674 677 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 851 856 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
During the primary and asymptomatic phases of HIV-1 infection, R5-tropic viruses predominate, whereas X4-tropic viruses are found in about 50% of infected individuals at late stages of HIV disease [32-34]. A more rapid decline in total CD4+ T cell counts is often associated with a switch from R5-tropic to X4-tropic HIV or R5/X4 HIV variants [35]. At present, it is unclear whether the switch to X4-tropic viruses is a cause or a consequence of the collapse of the immune system. Because TEMRA cells remain highly susceptible to X4-tropic viruses, it would be expected that these cells would also be rapidly depleted when an X4-tropic switch occurs. If TEMRA cells contain HIV-specific T cells or play some other protective role against infection, then elimination of these cells by X4-tropic viruses would further weaken the immune response against HIV-1 and facilitate immunological deterioration.
###end p 35
###begin p 36
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 47 51 47 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 486 490 486 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 95 98 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 167 170 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 203 208 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 334 339 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 620 625 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In summary, our results demonstrate that CD4+ TEMRA cells are present at a higher frequency in HIV-infected than uninfected individuals and are resistant to R5-tropic HIV infection, but not to X4-tropic HIV-1 infection. Studies focused on emergence of these effector memory T cell subsets will contribute to a better understanding of HIV-1 pathogenesis and the role of these cells during normal immune responses. Decoding the precise molecular mechanism of the intrinsic resistance of TEMRA cells to R5-tropic infection may have significant implications for developing novel approaches to endow this unique phenotype on HIV-1-susceptible T cells.
###end p 36
###begin title 37
Materials and Methods
###end title 37
###begin title 38
Cell isolation and culture.
###end title 38
###begin p 39
###xml 128 129 128 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b022">22</xref>
###xml 327 328 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 391 392 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 396 397 396 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 400 401 400 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 410 411 410 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 415 416 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 419 421 419 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 439 443 439 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 456 457 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 461 462 461 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 465 469 465 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b022">22</xref>
###xml 721 725 721 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 731 735 731 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 777 778 777 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 787 788 787 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 837 838 837 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b022">22</xref>
###xml 1046 1048 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b036">36</xref>
###xml 35 38 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 54 57 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
PBMCs were separated from blood of HIV-uninfected and HIV-infected individuals through Ficoll-Hypaque (Pharmacia, ). Resting CD4+ T cells were purified as previously described [22] and were at least 99.5% pure as determined by post-purification FACS analysis. To purify naive, central, and effector memory subsets, purified CD4+ cells were stained with CCR7 and CD45RO antibodies, and CD45RO-CCR7+ (TN), CD45RO+CCR7+ (TCM), CD45RO+CCR7- (TEMRO), and CD45RO-CCR7- (TEMRA) subsets were sorted using the flow cytometer (FACSAria; BD Biosciences, ). The culture medium used in all experiments was RPMI (Cellgro, ) and prepared as described before [22]. All cytokines were purchased from R&D Systems (). In some experiments, TEMRO and TEMRA subsets were further subdivided into CD57+ and CD57- subsets by flow sorting by staining purified CD4+ T cells with CCR7, CD45RO, and CD57 antibodies. Monocyte-derived DCs were generated as previously described [22]. The superantigen SEB (Sigma, ) was used to stimulate resting T cells in the presence of DCs [36].
###end p 39
###begin title 40
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants.
###end title 40
###begin p 41
###xml 398 399 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 414 416 414 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 468 469 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 84 87 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 130 142 <span type="species:ncbi:9606">participants</span>
###xml 148 151 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 222 225 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 424 429 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 547 552 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 637 649 <span type="species:ncbi:9606">participants</span>
Uninfected individuals were adults (ages 21-64, mean age was 32) with no history of HIV infection. Whole blood samples from adult participants with HIV infection were obtained during routine primary care visits. Among the HIV-infected individuals, 76% were Caucasian, 82% were male, the median (range) age was 41 (28-59) years, and 79% were receiving potent antiretroviral therapy. Median (IQR) CD4+ T cell and log10 plasma HIV-1 RNA values were 380 (270-592) cells/mm3 and 2.7 (2.6-3.8) copies/ml plasma, respectively, and 50% had fewer than 400 HIV-1 RNA copies/ml in plasma. There were no selection criteria based on race or sex. All participants provided written informed consent that was approved by the Vanderbilt Institutional Review Board.
###end p 41
###begin title 42
Virus production and infections.
###end title 42
###begin p 43
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b036">36</xref>
###xml 309 312 309 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b037">37</xref>
###xml 482 485 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b038">38</xref>
###xml 503 506 503 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b039">39</xref>
###xml 1021 1022 1021 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1032 1033 1032 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1086 1087 1086 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1098 1099 1098 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 42 45 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 201 204 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1129 1132 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
VSV-G pseudotyped replication-incompetent HIV were generated as previously described [36]. R5-tropic and X4-tropic replication-competent viruses were prepared similarly by transfecting 293T cells with HIV that encodes either R5-tropic (BaL) or X4-tropic (NL4-3) envelope and EGFP (Clontech, ) in place of the nef gene as previously described [37]. Wild-type virus (NL4-3) with X4-tropic or with R5-tropic envelope (BaL) and virus (R8) encoding heat stable antigen (HSA) in place of vpr [38] with intact nef gene were obtained from Chris Aiken (Vanderbilt University). Additional viruses used in this study were as follows. NL4-3-based proviral constructs encoding Env genes from R5-tropic proviral 92MW965.26, NL JRFL, NL YU2, and dual-tropic NL89.6 were obtained from Paul Bieniasz (Aaron Diamond AIDS Research Center) and have been previously described [39]. R5-tropic virus JRCSF and X4-tropic virus R9 were obtained from Vineet KewalRamani (National Cancer Institute [NCI]). Typically, viral titers ranged from 1 x 106 to 5 x 106 IFU/ml for replication-competent viruses and 10 x 106 to 30 x 106 IFU/ml for VSV-G pseudotyped HIV, as titered on CCR5-expressing Hut78 T cell lines (gift of Vineet KewalRamani, NCI). Viral replication in T cell cultures was determined by measuring p24 levels within supernatants by an ELISA.
###end p 43
###begin title 44
T cell apoptosis and cytokine assays.
###end title 44
###begin p 45
###xml 449 451 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b040">40</xref>
To determine apoptosis, T cells were stimulated with alpha-CD3 (OKT-3, ATCC)-coated plates in the presence of soluble alpha-CD28 (1 mug/ml; Pharmingen, ) for 18 h. T cell apoptosis was measured by PE-conjugated Annexin V according to manufacturer's instructions (BD Biosciences). Cytokines (IL-2, IL-4, IL-5, IL-10, TNF-alpha, IFN- gamma) in the supernatants were assayed using a commercially available cytometric bead assay (CBA) (BD Biosciences) [40], and analyzed using CBA 6-bead analysis software (BD Biosciences).
###end p 45
###begin title 46
FACS analysis.
###end title 46
###begin p 47
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b041">41</xref>
###xml 465 470 <span type="species:ncbi:9606">human</span>
###xml 736 740 <span type="species:ncbi:9925">goat</span>
###xml 746 751 <span type="species:ncbi:10090">mouse</span>
###xml 1055 1059 <span type="species:ncbi:9925">goat</span>
###xml 1065 1070 <span type="species:ncbi:10090">mouse</span>
T cells were stained with the relevant antibody on ice for 30 min (chemokine receptor staining performed at room temperature for 20 min) in PBS buffer containing 2% FCS and 0.1% sodium azide. Cells were then washed twice, fixed with 1% paraformaldehyde, and analyzed with a FACSCalibur or FACSAria flow cytometer. Live cells were gated based on forward and side scatter properties, and analysis was performed using FlowJo software (Tree Star, ). The following anti-human antibodies were used for staining: CD3, CD4, CD8, CD45RO, CD45RA, CD28, CD27, CD11b, CD57, CD7, CD62L, HLA-DR, CCR5 (all from BD Biosciences), CCR7, and CCR4 (R&D Systems). The CRTH2 antibody used for these experiments has been previously described [41]. Secondary goat-anti-mouse antibodies were conjugated with allophycocyanin or PE (BD Biosciences). For the intracellular p24 stain, fixation and permeabilization was performed using a commercial kit (BD Biosciences) according to the manufacturer's instructions. Subsequently, cells were stained with anti-p24 for 1 h, followed by goat-anti-mouse conjugated to allophycocyanin for 30 min.
###end p 47
###begin title 48
Virus-cell fusion assay.
###end title 48
###begin p 49
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b025">25</xref>
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV fusion assays were performed essentially as previously described [25]. Briefly, viruses carrying a beta-lactamase reporter protein fused to the amino terminus of the virion protein Vpr (BlaM-Vpr) were added to expanded T cell subsets at 37 degreesC for 2 h to allow virus-cell fusion. CCF2/AM (20 muM; Aurora Biosciences Corporation, ) was added, and the cultures were incubated for 14 h at room temperature. Cells were pelleted and resuspended in PBS, and the fluorescence was measured at 447 and 520 nm with a microplate fluorometer after excitation at 409 nm. Uncleaved CCF2 fluoresces green, due to fluorescence resonance energy transfer between the coumarin and fluorescein groups; however, cleavage by BlaM results in the dissociation of these fluorophores, and the emission spectrum shifts to blue. Thus, the ratio of blue to green cellular fluorescence is proportional to the overall extent of virus-cell fusion. Fluorescence ratios were calculated after subtraction of the average background fluorescence of control cultures containing no virus (blue values) and wells containing PBS (green values).
###end p 49
###begin title 50
###xml 25 28 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Quantitative analysis of HIV reverse transcription in target cells.
###end title 50
###begin p 51
###xml 421 423 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030058-b042">42</xref>
###xml 337 340 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Viral DNA was quantified by real-time PCR using an ABI 7700 instrument (PE Biosystems, ) with SYBR Green chemistry. The reaction mixtures (25 mul total volume) contained 2.5 mul of infected lysate, 12.5 mul of 2x SYBR Green PCR Master Mix (PE Biosystems), and 50 nM of each primer. A standard curve was prepared from serial dilutions of HIV plasmid DNA. The reactions were amplified and analyzed as previously described [42]. The sequences of primers (R and U5) specific for early products were 5'-GGCTAACTAGGGAACCCACTGCTT (forward) and 5'-CTGCTAGAGATTTTCCACACTGAC (reverse). The late-product primer sequences (R and 5NC) were 5'-TGTGTGCCCGTCTGTTGTGT (forward) and 5'-GAGTCCTGCGTCGAGAGAGC (reverse), as previously described.
###end p 51
###begin title 52
Statistical analysis.
###end title 52
###begin p 53
###xml 266 267 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistical analyses were performed using Stata version 9.0 (). T cell subset and clinical data are presented as means (standard deviation). Statistical significance between groups was determined by Wilcoxon rank sum test. Differences were considered significant at p < 0.05.
###end p 53
###begin title 54
Supporting Information
###end title 54
###begin title 55
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
CRTH2 Expression on CD4+ T Cell Subsets
###end title 55
###begin p 56
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 126 127 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 130 132 130 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 135 139 135 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 146 150 146 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 173 181 173 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g001">Figure 1</xref>
Purified CD4+ T cells were stained with CD45RO and CCR7 in conjunction with the CRTH2 antibody. Electronic gates were set on TN, TCM, TEMRO, and TEMRA cells as described in Figure 1, and expression of CRTH2 was analyzed by flow cytometry. The results show mean expression from ten different individuals.
###end p 56
###begin p 57
(146 KB TIF)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin title 59
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
CCR5 Expression on CD4+ T Cell Subsets
###end title 59
###begin p 60
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 133 135 133 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 138 142 138 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 149 153 149 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 176 184 176 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g001">Figure 1</xref>
###xml 346 347 346 347 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 356 358 356 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 369 373 369 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 385 389 385 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 443 447 443 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 453 457 453 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 466 468 466 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 500 501 500 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 510 511 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 11 14 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
PBMCs from HIV-positive individuals were stained with CD4, CD45RO, CCR7, and CCR5 antibodies. Electronic gates were set on CD4+ TN, TCM, TEMRO, and TEMRA cells as described in Figure 1, and expression of CCR5 was analyzed by flow cytometry. The results show CCR5 expression from 20 different individuals. The median CCR5 expression levels were: TN = 0.5, TCM = 11.96, TEMRO = 46, and TEMRA = 25.1. Statistical significance was determined for TEMRO and TEMRA versus TCM using the Student's two-tailed t test. * p < 0.05.
###end p 60
###begin p 61
(174 KB TIF)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin p 63
We thank Vineet KewalRamani, Jacek Hawiger, Richard D'Aquila, Karla Eger, and Amanda Antons for critical reading of the manuscript and comments. We thank Vineet KewalRamani, Paul Bieniasz, and Chris Aiken for cell lines and viral isolates, and Alison Motsinger for help with statistical analysis. We also thank Vanderbilt CFAR Immunology core facility for help with flow cytometry sorting.
###end p 63
###begin title 64
Abbreviations
###end title 64
###begin p 65
dendritic cell
###end p 65
###begin p 66
green fluorescent protein
###end p 66
###begin p 67
peripheral blood mononuclear cell
###end p 67
###begin p 68
###xml 34 37 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CCR5-tropic replication-competent HIV
###end p 68
###begin p 69
staphylococcal enterotoxin B
###end p 69
###begin p 70
central memory T cell
###end p 70
###begin p 71
T cell receptor
###end p 71
###begin p 72
effector memory T cell
###end p 72
###begin p 73
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
effector memory CD45RA+ T cell
###end p 73
###begin p 74
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
effector memory CD45RA- T cell
###end p 74
###begin p 75
naive T cell
###end p 75
###begin p 76
###xml 0 26 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 54 57 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
vesicular stomatitis virus glycoprotein G pseudotyped HIV
###end p 76
###begin p 77
###xml 35 38 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CXCR4-tropic replication-competent HIV
###end p 77
###begin title 78
References
###end title 78
###begin article-title 79
###xml 37 40 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Host factors and the pathogenesis of HIV-induced disease
###end article-title 79
###begin article-title 80
###xml 25 28 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause?
###end article-title 80
###begin article-title 81
###xml 19 47 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 49 52 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: A longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART)
###end article-title 81
###begin article-title 82
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
T cell depletion in HIV-1 infection: How CD4+ T cells go out of stock
###end article-title 82
###begin article-title 83
###xml 23 28 <span type="species:ncbi:9606">human</span>
Functional analysis of human T cell subsets defined by CD45 isoform expression
###end article-title 83
###begin article-title 84
Migration pathways and immunologic memory among T lymphocytes
###end article-title 84
###begin article-title 85
Homing of naive, memory and effector lymphocytes
###end article-title 85
###begin article-title 86
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
###end article-title 86
###begin article-title 87
Central memory and effector memory T cell subsets: Function, generation, and maintenance
###end article-title 87
###begin article-title 88
Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire
###end article-title 88
###begin article-title 89
###xml 165 193 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: A mechanism for CD4+ (T4) lymphocyte depletion
###end article-title 89
###begin article-title 90
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Preferential replication of HIV-1 in memory CD4+ subpopulation
###end article-title 90
###begin article-title 91
###xml 30 35 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 98 103 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
Differential requirements for HIV-1 replication in naive and memory CD4 T cells from asymptomatic HIV-1 seropositive carriers and AIDS patients
###end article-title 91
###begin article-title 92
###xml 72 77 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
###end article-title 92
###begin article-title 93
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV infection of CD45RA+ and CD45RO+ CD4+ T cells
###end article-title 93
###begin article-title 94
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro
###end article-title 94
###begin article-title 95
###xml 9 12 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CCR5 and HIV infection
###end article-title 95
###begin article-title 96
Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytes
###end article-title 96
###begin article-title 97
###xml 41 44 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The dynamics of CD4+ T-cell depletion in HIV disease
###end article-title 97
###begin article-title 98
###xml 47 52 <span type="species:ncbi:9606">human</span>
Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines
###end article-title 98
###begin article-title 99
###xml 52 57 <span type="species:ncbi:9606">human</span>
Selective expression of a novel surface molecule by human Th2 cells in vivo
###end article-title 99
###begin article-title 100
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 71 101 <span type="species:ncbi:11676">human immunodeficiency virus 1</span>
CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection
###end article-title 100
###begin article-title 101
###xml 27 55 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 57 60 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 88 91 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: Implications for HIV pathogenesis
###end article-title 101
###begin article-title 102
###xml 109 112 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection
###end article-title 102
###begin article-title 103
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes
###end article-title 103
###begin article-title 104
###xml 60 65 <span type="species:ncbi:9606">human</span>
Phenotypic and functional separation of memory and effector human CD8+ T cells
###end article-title 104
###begin article-title 105
###xml 83 86 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
###end article-title 105
###begin article-title 106
###xml 5 8 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells
###end article-title 106
###begin article-title 107
###xml 43 46 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
###end article-title 107
###begin article-title 108
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV pathogenesis: The first cut is the deepest
###end article-title 108
###begin article-title 109
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 27 30 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV preferentially infects HIV-specific CD4+ T cells
###end article-title 109
###begin article-title 110
###xml 24 59 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
###end article-title 110
###begin article-title 111
###xml 121 156 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals
###end article-title 111
###begin article-title 112
###xml 64 69 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
###end article-title 112
###begin article-title 113
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue
###end article-title 113
###begin article-title 114
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 63 68 <span type="species:ncbi:9606">human</span>
Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes
###end article-title 114
###begin article-title 115
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells
###end article-title 115
###begin article-title 116
###xml 13 48 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: Evidence supporting a role for Nef at the virion envelope
###end article-title 116
###begin article-title 117
###xml 77 112 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection
###end article-title 117
###begin article-title 118
###xml 64 69 <span type="species:ncbi:9606">human</span>
Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: Allergics vs. non-allergics
###end article-title 118
###begin article-title 119
CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s)
###end article-title 119
###begin article-title 120
###xml 25 28 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A quantitative assay for HIV DNA integration in vivo
###end article-title 120
###begin title 121
Figures and Tables
###end title 121
###begin title 122
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 16 21 <span type="species:ncbi:9606">Human</span>
###xml 45 48 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 62 65 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Distribution of Human CD4+ T Cell Subsets in HIV-Infected and HIV-Uninfected Individuals
###end title 122
###begin p 123
###xml 303 304 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 307 308 307 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 18 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 34 37 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
(A) PBMCs from HIV-uninfected and HIV-infected individuals were stained with purified CCR7 antibody, followed by allophycocyanin-conjugated anti-mouse IgG. After washing, cells were co-stained with CD4-FITC, CD3-Percp.Cy5.5, and CD45RO-PE. Expression of CCR7 and CD45RO were analyzed after gating on CD4+CD3+ T cells. Representative flow cytometry data from over 60 individuals are shown. The abbreviated definition of T cell subsets based on this staining profile is shown above the flow cytometry plots.
###end p 123
###begin p 124
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 189 190 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 193 194 193 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 244 245 244 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 253 254 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 258 259 258 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 263 265 263 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 273 274 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 278 279 278 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 283 287 283 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 295 296 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 309 313 309 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 321 322 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 326 327 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 41 44 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 60 63 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 341 344 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 361 364 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(B) CD4+ T cell subsets were analyzed in HIV-uninfected and HIV-infected individuals. Between 300,000 and 500,000 events were collected for each sample, and electronic gates were set on CD4+CD3+ T cells. Distribution and median percentages of TN (CD45RO-CCR7+), TCM (CD45RO+CCR7+), TEMRO (CD45RO+CCR7-), and TEMRA (CD45RO-CCR7-) cells in 33 HIV-infected and 30 HIV-uninfected individuals are shown.
###end p 124
###begin title 125
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 27 32 <span type="species:ncbi:9606">Human</span>
Phenotype of Distinct CD4+ Human T Cell Subsets
###end title 125
###begin p 126
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 128 129 128 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 132 134 132 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 137 141 137 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 148 152 148 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 175 183 175 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g001">Figure 1</xref>
###xml 282 285 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 387 390 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 404 407 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Purified CD4+ T cells were stained with CD45RO and CCR7 in conjunction with the antibodies shown. Electronic gates were set on TN, TCM, TEMRO, and TEMRA cells as described in Figure 1A, and expression of various T cell surface markers was analyzed. A representative profile from an HIV-infected individual is shown. Similar phenotype was observed in all four subsets of T cells from six HIV-infected and HIV-uninfected individuals.
###end p 126
###begin title 127
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Proliferation, Apoptosis, and Cytokine Profile of CD4+ T Cell Subsets
###end title 127
###begin p 128
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 39 42 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) Sorted CD4+ T cell subsets from an HIV-uninfected individual were activated using DCs pulsed with SEB (10 ng/ml) and expanded in IL-2-containing medium for 12 d. T cell subsets were then counted to determine fold expansion.
###end p 128
###begin p 129
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 226 227 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 235 236 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 248 250 248 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 252 253 252 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 264 268 264 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 270 271 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 285 289 285 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 291 292 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(B) Viability of purified CD4+ T cell subsets was determined using Annexin V staining after 18 h post-activation. Samples were analyzed by flow cytometry. Statistical significance was determined using the Student's two-tailed t test. TN: p = 0.4, TCM: p = 0.002, TEMRO: p = 0.15, and TEMRA: p = 0.3.
###end p 129
###begin p 130
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(C) Sorted CD4+ T cell subsets were activated using plate-bound anti-CD3 (3 mug/ml) and soluble anti-CD28 (1 mug/ml) antibodies. Supernatants were collected 18-24 h post-activation and analyzed for cytokine production using the cytometric bead assay. The results show the mean of four different experiments from four different individuals.
###end p 130
###begin title 131
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 83 88 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Expression of HIV-1 Coreceptors on CD4+ T Cell Subsets and Their Susceptibility to HIV-1 Infection
###end title 131
###begin p 132
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 187 195 187 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g001">Figure 1</xref>
###xml 25 28 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) CD4+ T cells from an HIV-uninfected individual were stained with CD45RO-PE and CCR7-FITC in conjunction with CCR5 and CXCR4 antibodies. CD4+ T cell subsets were gated as described in Figure 1, and expression of CCR5 and CXCR4 was analyzed.
###end p 132
###begin p 133
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 516 517 514 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 526 528 524 526 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 537 541 535 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 554 558 552 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 576 577 574 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 585 587 583 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 595 599 593 597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 611 615 609 613 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 638 639 636 637 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 647 649 645 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 657 661 655 659 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 673 677 671 675 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 41 44 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 201 204 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 209 212 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 220 223 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 510 513 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 570 573 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 632 635 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(B) Purified CD4+ T cell subsets from an HIV-uninfected individual were activated using plate-bound anti-CD3 (3 mug/ml) and soluble anti-CD28 (1 mug/ml) antibodies and concurrently infected with VSV-G.HIV, R5.HIV, or X4.HIV. Percent infected cells was determined by GFP expression of T cells on day 5 and 12 post-infection (p.i.). The results are representative of one of five independent experiments using T cell subsets isolated from five different individuals. The median infection values at day 5 were: R5-HIV: TN = 1.1, TCM = 9.5, TEMRO = 5.4, and TEMRA = 0.85; X4-HIV: TN = 17, TCM = 36, TEMRO = 43, and TEMRA = 33; and VSV-G.HIV: TN = 44, TCM = 48, TEMRO = 19, and TEMRA = 6.5.
###end p 133
###begin title 134
###xml 35 36 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Replication of HIV-1 Strains in CD4+ T Cell Subsets
###end title 134
###begin p 135
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 62 70 62 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030058-g004">Figure 4</xref>
###xml 124 129 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Purified CD4+ T cell subsets were activated through TCR as in Figure 4 and concurrently infected with replication-competent HIV-1.
###end p 135
###begin p 136
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 7 10 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 18 21 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 72 75 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 91 94 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) R5.HIV and X4.HIV infection time course of CD4+ T cell subsets from HIV-uninfected and HIV-infected individuals.
###end p 136
###begin p 137
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 68 71 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 79 82 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 136 139 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(B) Supernatants from purified CD4+ T cell subsets infected with R5.HIV and X4.HIV cultures were collected at different time points and HIV p24 levels were measured by ELISA. The percentage of infected cells was determined by GFP expression at different time points post-infection by flow cytometry. The results are representative of one of five independent experiments from different individuals.
###end p 137
###begin p 138
###xml 408 409 408 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 420 422 420 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</sub>
###xml 436 440 436 440 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 275 278 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 381 384 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(C) Infection of T cell subsets with HIV-1 expressing different primary isolate envelopes. Percent infected T cells was determined by intracellular p24 staining of T cells on day 4, 6, and 8 post-infection. The T cell subsets in this experiment were also infected with VSG-V.HIV, where the percent infected cells was determined by GFP expression at 4 day post-infection. The VSV-G-HIV infection was 33% for TN, 33% for TCM, and 9% for TEMRA cells.
###end p 138
###begin title 139
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Replication of HIV-1 strains in CD57+ CD4+ T cell subsets
###end title 139
###begin p 140
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 138 141 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 148 151 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Effector memory T cell subsets were subdivided into CD57+ and CD57- portions by sorting, then activated and concurrently infected with R5.HIV or X4.HIV. The percentage of infected cells was determined by GFP expression at different time points post-infection by flow cytometry. The results are representative of one of five independent experiments from different individuals.
###end p 140
###begin title 141
###xml 71 75 71 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
Identifying the Block in R5-Tropic and VSV-G Pseudotyped Infection of TEMRA Cells
###end title 141
###begin p 142
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Purified CD4+ T cell subsets were activated using DCs pulsed with SEB (10 ng/ml) and expanded in IL-2-containing medium for 10 d.
###end p 142
###begin p 143
###xml 144 147 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) Day 12 expanded subsets were stained for CCR5 expression. Cells were then reactivated with SEB-pulsed DCs and subsequently infected with R5.HIV at an MOI of 5. At day 6 post-infection, cells were then stained for CCR5, and infection was analyzed as determined by GFP expression by flow cytometry.
###end p 143
###begin p 144
###xml 109 110 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 128 129 125 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 7 10 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 15 18 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 30 33 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(B) R5.HIV, X4.HIV, and VSV-G.HIV carrying a beta-lactamase reporter protein were incubated with expanded CD4+ T cell subsets, TN cells, and Jurkat T cell line at 37 degreesC for 2 h to allow virus-cell fusion, CCF2/AM (20 muM) was added, and fluorescence was measured as described in Materials and Methods. Fluorescence ratios were calculated after subtraction of the average background fluorescence.
###end p 144
###begin p 145
###xml 92 95 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 100 103 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 114 117 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 217 220 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(C) Expanded subsets were reactivated with SEB-pulsed DCs and subsequently infected with R5.HIV, X4.HIV, or VSV-G.HIV at an MOI of 5 for 12 h. Cells were then lysed and processed for real-time PCR analysis using late HIV transcript primers.
###end p 145
###begin p 146
###xml 104 107 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(D) Reactivated expanded T cell subsets were lysed and processed for real-time PCR analysis using early HIV transcript primers. All infections were performed at an MOI of 5. The results are representative of one of five independent experiments using T cell subsets isolated from five different individuals.
###end p 146
###begin title 147
###xml 21 23 21 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 51 54 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Association between TEM Subsets and CD4 Numbers in HIV-Infected Individuals
###end title 147
###begin p 148
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 90 92 90 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 112 114 112 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EM</sub>
###xml 147 151 147 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 151 155 151 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 156 160 156 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 160 163 160 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 169 173 169 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 173 176 173 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 177 181 177 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 181 185 181 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 226 227 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 308 312 308 312 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 351 352 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 370 374 370 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 391 392 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 508 512 508 512 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRA</sub>
###xml 512 516 512 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 599 603 599 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EMRO</sub>
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV-infected individuals were separated into three groups based on percent of their CD4+ TEM cells. The medium TEM population was subdivided into TEMROhighTEMRAlow and TEMROlowTEMRAhigh, and the number of total CD4 cells and TN cells in each group was calculated. We set the cut-off percentage for defining TEMRO high and low proportions as 28% of CD4+ T cells and for TEMRA cells, 8% of CD4+ T cells. Statistical analysis was performed with only the medium group since the bottom group did not contain any TEMRAhigh cells (range: 1.6%-5.5%) and within the top group all individuals contained high TEMRO cells (range: 31%-59%). Statistical significance between groups was determined by Wilcoxon rank sum test.
###end p 148
###begin p 149
currency Current address: Department of Microbiology, New York University School of Medicine, New York, New York, United States of America
###end p 149
###begin p 150
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. DU conceived the project. DU and KOR designed the experiments. KOR, SMG, and ML performed the experiments. KOR, SMG, ML, and DU analyzed the data. MT, SAK, TH, and DWH contributed reagents/materials/analysis tools. KOR and DU wrote the paper.
###end p 150
###begin p 151
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This work was supported by National Institutes of Health grant R01-AI49131 to DU and by R01-AI39966 to SKA, and by the Elizabeth Glaser Pediatric AIDS Foundation to SKA.
###end p 151
###begin p 152
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 152

